We are live on ! Find out more
LC

Lindbrook Capital Portfolio holdings

AUM $1.08B
1-Year Est. Return 10.14%
This Fund
S&P 500
This Quarter Est. Return
+7.65%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
AUM
$939M
AUM Growth
+$86.2M
Cap. Flow
+$29.6M
Cap. Flow %
3.15%
Top 10 Hldgs %
46.18%
Holding
2,925
New
150
Increased
988
Reduced
857
Closed
215

Sector Composition

Rank Sector Weight
1 Financials 16.18%
2 Technology 15.3%
3 Healthcare 6.27%
4 Consumer Discretionary 3.61%
5 Industrials 3.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
F icon
301
Ford
F
$55.7B
$226K 0.02%
14,931
+1,542
+12% +$19.5K
VRSN icon
302
VeriSign
VRSN
$26.6B
$224K 0.02%
993
+3
+0.3% +$661
CPRT icon
303
Copart
CPRT
$27.5B
$224K 0.02%
4,908
-66
-1% -$2.74K
EEM icon
304
iShares MSCI Emerging Markets ETF
EEM
$29.5B
$223K 0.02%
5,642
+4,042
+253% +$159K
MRSH
305
Marsh
MRSH
$91.5B
$223K 0.02%
1,185
+8
+0.7% +$1.42K
PAVE icon
306
Global X US Infrastructure Development ETF
PAVE
$15.2B
$222K 0.02%
7,072
HPQ icon
307
HP
HPQ
$27.5B
$221K 0.02%
7,194
+399
+6% +$12K
KR icon
308
Kroger
KR
$34.8B
$221K 0.02%
4,698
-154
-3% -$7.35K
FE icon
309
FirstEnergy
FE
$27.5B
$220K 0.02%
5,656
+510
+10% +$20K
MYD
310
DELISTED
BlackRock MuniYield Fund
MYD
$219K 0.02%
21,000
SNY icon
311
Sanofi
SNY
$104B
$217K 0.02%
4,021
+215
+6% +$11.6K
ROK icon
312
Rockwell Automation
ROK
$49B
$215K 0.02%
652
-9
-1% -$2.6K
UMC icon
313
United Microelectronic
UMC
$46.9B
$214K 0.02%
27,114
+617
+2% +$5.08K
IWN icon
314
iShares Russell 2000 Value ETF
IWN
$14.6B
$213K 0.02%
1,513
-742
-33% -$100K
ECL icon
315
Ecolab
ECL
$79.9B
$212K 0.02%
1,138
+397
+54% +$68.3K
EWW icon
316
iShares MSCI Mexico ETF
EWW
$1.99B
$209K 0.02%
+3,367
New +$206K
UBS icon
317
UBS Group
UBS
$176B
$209K 0.02%
10,295
-917
-8% -$18.4K
LVS icon
318
Las Vegas Sands
LVS
$29.6B
$208K 0.02%
3,588
+37
+1% +$2.19K
LH icon
319
Labcorp
LH
$25.9B
$205K 0.02%
991
+6
+0.6% +$1.16K
PXD
320
DELISTED
Pioneer Natural Resource Co.
PXD
$205K 0.02%
989
+19
+2% +$4K
BIIB icon
321
Biogen
BIIB
$30.7B
$203K 0.02%
713
+14
+2% +$4.17K
DXCM icon
322
DexCom
DXCM
$32B
$203K 0.02%
1,579
+1
+0.1% +$121
OMC icon
323
Omnicom Group
OMC
$23.4B
$201K 0.02%
2,116
+5
+0.2% +$464
GILD icon
324
Gilead Sciences
GILD
$165B
$201K 0.02%
2,608
+195
+8% +$15.6K
LEA icon
325
Lear
LEA
$8.18B
$199K 0.02%
1,387
-72
-5% -$9.51K

Similar funds

Lindbrook Capital's Q2 2023 Portfolio in Review

As of Q2 2023, Lindbrook Capital held 2,925 positions worth $939M, up 10% from $853M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Lindbrook Capital deployed $29.6M of net new capital in Q2 2023, opening 150 new positions and adding to 988 existing holdings. Its largest new stake was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $6.88M trimmed.

  • Lindbrook Capital's largest Q2 2023 buy was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.
  • Lindbrook Capital added most to Vanguard Total International Stock ETF in Q2 2023, an estimated $5.37M increase.
  • Lindbrook Capital's biggest Q2 2023 reduction was Vertex Pharmaceuticals, cutting an estimated $6.88M.
  • Lindbrook Capital fully exited MoneyGram International, Inc. New in Q2 2023, selling an estimated $627K.
  • Lindbrook Capital's ten largest holdings make up 46% of its $939M portfolio in Q2 2023.
  • Lindbrook Capital opened 150 new positions and closed 215 in Q2 2023.
  • Lindbrook Capital's portfolio value rose 10% quarter-over-quarter to $939M.

Based on Lindbrook Capital's 13F filing for Q2 2023, filed 31 Jul 2023.